Literature DB >> 12845301

Localized 1H-MR spectroscopy in moyamoya disease before and after revascularization surgery.

Soo Mee Lim1, Hye-Young Choi, Jung Soo Suh, Jung Hee Lee, Keun Ho Lim, Dae Chul Suh, Ho Kyu Lee, Tae-Hwan Lim, Young Shin Ra.   

Abstract

OBJECTIVE: To evaluate, using localized proton magnetic resonance spectroscopy ((1)H-MRS), the cerebral metabolic change apparent after revascularization surgery in patients with moyamoya disease.
MATERIALS AND METHODS: Sixteen children with moyamoya disease and eight age-matched normal controls underwent MR imaging, MR angiography, conventional angiography, and (99m)Tc- ECD SPECT. Frontal white matter and the basal ganglia of both hemispheres were subjected to localized (1)H-MRS, and after revascularization surgery, four patients underwent follow-up (1)H-MRS.
RESULTS: Decreased NAA/Cr ratios (1.35+/-0.14 in patients vs. 1.55+/-0.24 in controls) and Cho/Cr ratios (0.96+/-0.13 in patients vs. 1.10+/-0.11 in controls) were observed in frontal white matter. After revascularization surgery, NAA/Cr and Cho/Cr ratios in this region increased. In the basal ganglia, there is no abnormal metabolic ratios.
CONCLUSION: Localized (1)H-MRS revealed abnormal metabolic change in both hemispheres of children with moyamoya disease. Because of its non-invasive nature, (1)H-MRS is potentially useful for the preoperative evaluation of metabolic abnormalities and their postoperative monitoring.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845301      PMCID: PMC2698073          DOI: 10.3348/kjr.2003.4.2.71

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


  29 in total

1.  SPECT, magnetic resonance and angiographic features in a moyamoya patient before and after external-to-internal carotid artery bypass.

Authors:  K Ohashi; M Fernandez-Ulloa; L C Hall
Journal:  J Nucl Med       Date:  1992-09       Impact factor: 10.057

2.  Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease.

Authors:  T Ishikawa; K Houkin; H Kamiyama; H Abe
Journal:  Stroke       Date:  1997-06       Impact factor: 7.914

3.  The scintigraphic appearance of childhood moyamoya disease on cerebral perfusion imaging.

Authors:  J H Miller; A Khonsary; C Raffel
Journal:  Pediatr Radiol       Date:  1996-12

4.  Human brain infarction: proton MR spectroscopy.

Authors:  J H Duijn; G B Matson; A A Maudsley; J W Hugg; M W Weiner
Journal:  Radiology       Date:  1992-06       Impact factor: 11.105

5.  Surgical treatment of moyamoya disease: operative technique for encephalo-duro-arterio-myo-synangiosis, its follow-up, clinical results, and angiograms.

Authors:  K Kinugasa; S Mandai; I Kamata; K Sugiu; T Ohmoto
Journal:  Neurosurgery       Date:  1993-04       Impact factor: 4.654

6.  Proton magnetic resonance spectroscopy in children with moyamoya disease.

Authors:  H Shimizu; R Shirane; S Fujiwara; A Takahashi; T Yoshimoto
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

7.  Cerebral metabolic differences between the severe and critical hypoperfused brain.

Authors:  J van der Grond; L M Ramos; B C Eikelboom; W P Mali
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

8.  Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease.

Authors:  Y Inoue; T Momose; K Machida; N Honda; K Tsutsumi
Journal:  J Nucl Med       Date:  1993-11       Impact factor: 10.057

9.  Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease.

Authors:  H Touho; J Karasawa; H Ohnishi
Journal:  Stroke       Date:  1996-02       Impact factor: 7.914

10.  Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy.

Authors:  R Kreis; B D Ross; N A Farrow; Z Ackerman
Journal:  Radiology       Date:  1992-01       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.